Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

3

Long-term Follow-up of Patients Treated with Interferon Alfa for Chronic Hepatitis B

Jong Eun Yeon, M.D., Yeon Seok Seo, M.D., Yoon Hong Kim, M.D., Sang Hoon Park, M.D., Oh Sang Kwon, M.D., Kwan Soo Byun, M.D., and Chang Hong Lee, M.D.

Clin Mol Hepatol. 1999;5(1):12-21. Published online January 1, 2000

View: 2031 Download: 15

Immunogenicity and Safety of a 20 ㎍ Dose of the Green Cross Recombinant Hepatitis B Vaccine (HG -Ⅱ) in Healthy Adults

Kye Heui Lee , Ok Jae Lee , Young Chai Kim , Ran Namgung , Young Mo Sohn

Clin Mol Hepatol. 1997;3(1):58-64. Published online January 1, 1970

View: 1869 Download: 16

Lipid Peroxidation in Chronic Liver Diseases Type B

Kyung Chul Kim , Kwan Sik Lee , Kwang Hyub Han , Won Choi , Chae Yoon Chon , Sang In Lee , Young Myung Moon , Jin Kyung Kang , In Suh Park , Hye Young Kim

Clin Mol Hepatol. 1997;3(1):40-49.

View: 2016 Download: 16

A Study on HBV Precore Mutant in Liver Tissues of Chronic Hepatitis B Patiets

Hae Chul Chung , Yeong Hong Park , Jung Myung Chung

Clin Mol Hepatol. 1996;2(2):145-159.

View: 2076 Download: 14

4

A Case of Hypothyroidism Induced by Alpha - Interferon Therapy for Chronic Hepatitis B

So Young Kwon , Jong Eun Yeon , Sei Hyun Baik , Jin Ho Kim , Young Tae Baik , Kwan Soo Byun , Chang Hong Lee

Clin Mol Hepatol. 1996;2(1):77-81.

View: 1875 Download: 12

3

Hepatitis B and C Virus in Hepatocellular Carcinoma

Young Soo Kim, Kwang Jae Lee, Young Soo Moon, Ki Baek Hahm, Jin Hong Kim, Sung Won Cho, Sang In Lee, Chan Sup Shim*

Clin Mol Hepatol. 1996;2(1):61-67. Published online January 1, 2000

View: 8808 Download: 19

Evaluation of Oral Thymomodulin Effect on the Patients with Chronic Viral Hepatitis B

Chul Hun Chung , Soong Hwan Lee , Yong Hyeon Jo , Yeon Soo kim , Seung Woo Nam , Oh Young Lee , Dong Soo Ha , Joo Hyun Sohn , Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):47-53.

View: 2991 Download: 37

Comparison of the Incidence of Hepatocellular Carcinoma in HBV - and HCV - associated Liver Cirrhosis ; A Prospective Study

Hyo Suk lee , Jun Haeng Lee , Moon Suk Choi , Chung Yong kim

Clin Mol Hepatol. 1996;2(1):21-28.

View: 2093 Download: 14

Review

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective

Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen

Received November 14, 2022 Accepted December 23, 2022

DOI: https://doi.org/10.3350/cmh.2022.0399 [Epub ahead of print]

View: 665 Download: 108

Original Article

The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase

Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim

Received October 19, 2022 Accepted January 3, 2023

DOI: https://doi.org/10.3350/cmh.2022.0322 [Accepted]

View: 448 Download: 54

Review

The role of different viral biomarkers on the management of chronic hepatitis B For special issue ‘Challenging issues in the treatment of viral hepatitis’

Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen

Received December 14, 2022 Accepted January 15, 2023

DOI: https://doi.org/10.3350/cmh.2022.0448 [Accepted]

View: 433 Download: 75

Letter to the Editor

Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"

Chia-Ming Chu, Yun-Fan Liaw.

Received January 19, 2023 Accepted January 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0018 [Accepted]

View: 213 Download: 22

Review

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

Shang-Chin Huang, Chun-Jen Liu

Received November 27, 2022 Accepted January 5, 2023

DOI: https://doi.org/10.3350/cmh.2022.0422 [Epub ahead of print]

View: 523 Download: 120

Development of hepatocellular carcinoma in untreated and treated patients with chronic hepatitis B virus infection

Chih-Lin Lin, Jia-Horng Kao

Received October 31, 2022 Accepted February 12, 2023

DOI: https://doi.org/10.3350/cmh.2022.0342 [Accepted]

View: 382 Download: 75

Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy

Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka

Received December 2, 2022 Accepted March 7, 2023

DOI: https://doi.org/10.3350/cmh.2022.0434 [Accepted]

View: 223 Download: 40

Editorial

The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise

Moon Haeng Hur, Jeong-Hoon Lee

Received February 28, 2023 Accepted March 7, 2023

DOI: https://doi.org/10.3350/cmh.2023.0079 [Accepted]

View: 74 Download: 8

Review

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Received March 9, 2023 Accepted March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0099 [Accepted]

View: 192 Download: 30

Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm

Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao

Received November 26, 2022 Accepted March 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0420 [Accepted]

View: 125 Download: 22

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

First decision

09 Days

Publication after acceptance

06 Days

*Last 12 months

Viewed By 5619	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3588	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3261	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2718	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2613	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology

Cited By 88	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 33	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future